Q3 FY2026 · ended Sep 30, 2026 · Revenue $222.56M, +12.9% YoY · Filed Nov 5, 2026
U S Physical Therapy Inc /NV (USPH) files with the SEC under industry code 8000, Services-Health Services. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $222.6 million and net income of $11.0 million. Free cash flow was $20.7 million. As of Sep 30, 2026 it held $38.2 million in cash and investments and $419.9 million in total debt.
Revenue
$222.56M
+12.9% vs year-ago quarter
Net income
$11.04M
-15.9% vs year-ago quarter
Operating cash flow
$25.72M
+29.0% vs year-ago quarter
Free cash flow
$20.65M
+32.2% vs year-ago quarter
EPS
$-1.04
-316.7% vs year-ago quarter
Dividend per share
$0.46
+2.2% vs year-ago quarter
Shares outstanding
14.93M
-1.8% vs year-ago quarter
Net cash
$-381.71M
Q3 FY2026
Operating margin
9.1%
TTM
Company profile
- Industry
- Services-Health Services (SIC 8000)
- Listed as
- USPH (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Houston, TX
- SEC filer status
- Large accelerated filer
- SEC CIK
- 885978
Other Services-Health Services companies
- LifeStance Health Group, Inc. LFST
- Privia Health Group, Inc. PRVA
- GeneDx Holdings Corp. WGS
- Pennant Group, Inc. PNTG
- InnovAge Holding Corp. INNV
- Omada Health, Inc. OMDA
- P3 Health Partners Inc. PIII
- Alps Group Inc ALPS
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $222.6M | $214.1M | $198.3M | $202.7M | $197.1M |
| Operating income | $25.1M | $21.9M | $12.5M | $16.8M | $25.3M |
| Net income | $11.0M | $9.9M | $5.0M | $4.2M | $13.1M |
| Diluted EPS | -$1.04 | $0.25 | -$0.12 | $0.27 | $0.48 |
| Operating cash flow | $25.7M | $34.4M | $3.8M | $24.9M | $19.9M |
| Free cash flow | $20.7M | $29.0M | -$1.6M | $21.0M | $15.6M |
| Total assets | $1.3B | $1.2B | $1.2B | $1.2B | $1.2B |
| Total liabilities | $508.4M | $482.2M | $459.2M | $433.8M | $413.8M |
| Stockholders' equity | $429.3M | $448.7M | $469.0M | $476.4M | $503.6M |
| Cash and investments | $38.2M | $24.9M | $28.4M | $35.6M | $31.1M |
| Total debt | $419.9M | $385.8M | $362.8M | $315.2M | $308.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 28, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 21, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Aug 14, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 10, 2026 | Aug 6, 2026 |
All 1001 U S Physical Therapy Inc /NV SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.